Critical influence of cytokines and immune cells in autoimmune gastritis

References

• Seidlitz T, Koo B-K, Stange DE. Gastric organoids—an in vitro model system for the study of gastric development and road to personalized medicine. Cell Death & Differentiation. 2021;28(1):1–10.
   PubMed Web of Science ®Google Scholar
• Ilic M, Ilic I. Epidemiology of stomach cancer. World J Gastroenterol. 2022;28(12):1187–1203.
   PubMed Web of Science ®Google Scholar
• Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol. 1995;19:s37–s43.
   PubMed Web of Science ®Google Scholar
• Dilaghi E, Baldaro F, Pilozzi E, et al. Pseudopyloric metaplasia is not associated with the development of gastric cancer. Am J Gastroenterol. 2021;116(9):1859–1867.
   Google Scholar
• Shah SC, Piazuelo MB, Kuipers EJ, et al. AGA clinical practice update on the diagnosis and management of atrophic gastritis: expert review. Gastroenterology. 2021;161(4):1325–1332.e7.
   PubMed Web of Science ®Google Scholar
• Sousa C, Ferreira R, Azevedo NF, et al. Helicobacter pylori infection: from standard to alternative treatment strategies. Crit Rev Microbiol. 2022;48(3):376–396.
   PubMed Web of Science ®Google Scholar
• Terao S, Suzuki S, Yaita H, et al. Multicenter study of autoimmune gastritis in Japan: clinical and endoscopic characteristics. Dig Endosc. 2020;32(3):364–372.
   PubMed Web of Science ®Google Scholar
• Coati I, Fassan M, Farinati F, et al. Autoimmune gastritis: pathologist’s viewpoint. World J Gastroenterol. 2015;21(42):12179–12189.
   PubMed Web of Science ®Google Scholar
• Neumann WL, Coss E, Rugge M, et al. Autoimmune atrophic gastritis–pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol. 2013;10(9):529–541.
   PubMed Web of Science ®Google Scholar
• Fox JG, Wang TC. Inflammation, atrophy, and gastric cancer. J Clin Invest. 2007;117(1):60–69.
   PubMed Web of Science ®Google Scholar
• Rustgi SD, Bijlani P, Shah SC. Autoimmune gastritis, with or without pernicious anemia: epidemiology, risk factors, and clinical management. Therap Adv Gastroenterol. 2021;14:17562848211038771.
   Web of Science ®Google Scholar
• Lenti MV, Rugge M, Lahner E, et al. Autoimmune gastritis. Nat Rev Dis Primers. 2020;6(1):56.
   PubMed Web of Science ®Google Scholar
• Kamada T, Maruyama Y, Monobe Y, et al. Endoscopic features and clinical importance of autoimmune gastritis. Dig Endosc. 2022;34(4):700–713.
   PubMed Web of Science ®Google Scholar
• Panimolle F, Tiberti C, Granato S, et al. Evidence of increased humoral endocrine organ-specific autoimmunity in severe and classic X-chromosome aneuploidies in comparison with 46, XY control subjects. Autoimmunity. 2018;51(4):175–182.
   PubMed Web of Science ®Google Scholar
• Troilo A, Grassi A, Petrone L, et al. Intrinsic factor recognition promotes T helper 17/T helper 1 autoimmune gastric inflammation in patients with pernicious anemia. Oncotarget. 2019;10(30):2921–2929.
   PubMedGoogle Scholar
• Pikkarainen S, Martelius T, Ristimaki A, et al. A High prevalence of gastrointestinal manifestations in common variable immunodeficiency. Am J Gastroenterol. 2019;114(4):648–655.
   PubMed Web of Science ®Google Scholar
• Mafi S, Mansoori B, Taeb S, et al. mTOR-Mediated regulation of immune responses in cancer and tumor microenvironment. Front Immunol. 2021;12:774103.
   PubMed Web of Science ®Google Scholar
• Li L, Yu R, Cai T, et al. Effects of immune cells and cytokines on inflammation and immunosuppression in the tumor microenvironment. Int Immunopharmacol. 2020;88:106939.
   PubMed Web of Science ®Google Scholar
• Alderuccio F, Toh B, Tan S-S, et al. An autoimmune disease with multiple molecular targets abrogated by the transgenic expression of a single autoantigen in the thymus. J Exp Med. 1993;178(2):419–426.
   PubMed Web of Science ®Google Scholar
• Di Sabatino A, Lenti MV, Giuffrida P, et al. New insights into immune mechanisms underlying autoimmune diseases of the gastrointestinal tract. Autoimmun Rev. 2015;14(12):1161–1169.
   PubMed Web of Science ®Google Scholar
• Shevach EM, McHugh RS, Piccirillo CA, et al. Control of T‐cell activation by CD4+ CD25+ suppressor T cells. Immunol Rev. 2001;182(1):58–67.
   PubMedGoogle Scholar
• Katakai T, Mori KJ, Masuda T, et al. Differential localization of Th1 and Th2 cells in autoimmune gastritis. Int Immunol. 1998;10(9):1325–1334.
   PubMed Web of Science ®Google Scholar
• Karlsson F, Burman P, Lööf L, et al. Major parietal cell antigen in autoimmune gastritis with pernicious anemia is the acid-producing H+, K+-adenosine triphosphatase of the stomach. J Clin Invest. 1988;81(2):475–479.
   PubMed Web of Science ®Google Scholar
• D’elios MM, Bergman MP, Azzurri A, et al. H+, K+-ATPase (proton pump) is the target autoantigen of Th1-type cytotoxic T cells in autoimmune gastritis. Gastroenterology. 2001;120(2):377–386.
   PubMed Web of Science ®Google Scholar
• Raphael I, Nalawade S, Eagar TN, et al. T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine. 2015;74(1):5–17.
   PubMed Web of Science ®Google Scholar
• Lopez-Diaz L, Hinkle KL, Jain RN, et al. Parietal cell hyperstimulation and autoimmune gastritis in cholera toxin transgenic mice. Am J Physiol Gastrointest Liver Physiol. 2006;290(5):G970–G979.
   PubMed Web of Science ®Google Scholar
• Tu SP, Quante M, Bhagat G, et al. IFN-gamma inhibits gastric carcinogenesis by inducing epithelial cell autophagy and T-cell apoptosis. Cancer Res. 2011;71(12):4247–4259.
   PubMed Web of Science ®Google Scholar
• Candon S, McHugh RS, Foucras G, et al. Spontaneous organ-specific Th2-mediated autoimmunity in TCR transgenic mice. J Immunol. 2004;172(5):2917–2924.
   PubMed Web of Science ®Google Scholar
• Suri-Payer E, Amar A, McHugh R, et al. Post-thymectomy autoimmune gastritis: fine specificity and pathogenicity of anti-H/K ATPase-reactive T cells. Eur J Immunol. 1999;29(2):669–677.
   PubMed Web of Science ®Google Scholar
• Harakal J, Rival C, Qiao H, et al. Regulatory T cells control Th2-dominant murine autoimmune gastritis. J Immunol. 2016;197(1):27–41.
   PubMed Web of Science ®Google Scholar
• Noto CN, Hoft SG, Bockerstett KA, et al. IL13 Acts directly on gastric epithelial cells to promote metaplasia development during chronic gastritis. Cell Mol Gastroenterol Hepatol. 2022;13(2):623–642.
   PubMed Web of Science ®Google Scholar
• Barrett SP, Gleeson PA, De Silva H, et al. Interferon‐γ is required during the initiation of an organ‐specific autoimmune disease. Eur J Immunol. 1996;26(7):1652–1655.
   PubMed Web of Science ®Google Scholar
• Stummvoll GH, DiPaolo RJ, Huter EN, et al. Th1, Th2, and Th17 effector T cell-induced autoimmune gastritis differs in pathological pattern and in susceptibility to suppression by regulatory T cells. J Immunol. 2008;181(3):1908–1916.
   PubMed Web of Science ®Google Scholar
• Bockerstett KA, Osaki LH, Petersen CP, et al. Interleukin-17A promotes parietal cell atrophy by inducing apoptosis. Cell Mol Gastroenterol Hepatol. 2018;5(4):678–690 e1.
   PubMed Web of Science ®Google Scholar
• Vojdani A, Lambert J. The Role of Th17 in neuroimmune disorders: target for CAM therapy. Part I. Evid Based Complement Alternat Med. 2011;2011:927294.
   PubMedGoogle Scholar
• Choi G, Park Y-J, Cho M, et al. A critical role for Th17 cell-derived TGF-β1 in regulating the stability and pathogenicity of autoimmune Th17 cells. Exp Mol Med. 2021;53(5):993–1004.
   PubMed Web of Science ®Google Scholar
• Stephens GL, Wang Q, Swerdlow B, et al. Kynurenine 3‐monooxygenase mediates inhibition of T h17 differentiation via catabolism of endogenous aryl hydrocarbon receptor ligands. Eur J Immunol. 2013;43(7):1727–1734.
   PubMed Web of Science ®Google Scholar
• Xu J, Yang Y, Qiu G, et al. c-Maf regulates IL-10 expression during Th17 polarization. J Immunol. 2009;182(10):6226–6236.
   PubMed Web of Science ®Google Scholar
• McHugh R. Autoimmune gastritis is a well-defined autoimmune disease model for the study of CD4+ CD25+ T cell-mediated suppression. Curr Top Microbiol Immunol. 2005;293:153–177.
   Google Scholar
• Suri-Payer E, Cantor H. Differential cytokine requirements for regulation of autoimmune gastritis and colitis by CD4+ CD25+ T cells. J Autoimmun. 2001;16(2):115–123.
   PubMed Web of Science ®Google Scholar
• Laurie KL, Van Driel IR, Gleeson PA. The role of CD4+ CD25+ immunoregulatory T cells in the induction of autoimmune gastritis. Immunol Cell Biol. 2002;80(6):567–573.
   PubMed Web of Science ®Google Scholar
• Shevach EM, DiPaolo RA, Andersson J, et al. The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells. Immunol Rev. 2006;212(1):60–73.
   PubMedGoogle Scholar
• Nguyen T-LM, Sullivan NL, Ebel M, et al. Antigen-Specific TGF-β–induced regulatory T cells secrete chemokines, regulate T cell trafficking, and suppress ongoing autoimmunity. J Immunol. 2011;187(4):1745–1753.
   PubMed Web of Science ®Google Scholar
• Tu E, Bourges D, Gleeson PA, et al. Pathogenic T cells persist after reversal of autoimmune disease by immunosuppression with regulatory T cells. Eur J Immunol. 2013;43(5):1286–1296.
   PubMed Web of Science ®Google Scholar
• Bockerstett KA, DiPaolo RJ. Regulation of gastric carcinogenesis by inflammatory cytokines. Cell Mol Gastroenterol Hepatol. 2017;4(1):47–53.
   PubMed Web of Science ®Google Scholar
• Gaffen SL. An overview of IL-17 function and signaling. Cytokine. 2008;43(3):402–407.
   PubMed Web of Science ®Google Scholar
• Oksanen AM, Haimila KE, Rautelin HI, et al. Immunogenetic characteristics of patients with autoimmune gastritis. World J Gastroenterol. 2010;16(3):354–358.
   PubMed Web of Science ®Google Scholar
• Munari F, Fassan M, Capitani N, et al. Cytokine BAFF released by Helicobacter pylori-infected macrophages triggers the Th17 response in human chronic gastritis. J Immunol. 2014;193(11):5584–5594.
   PubMed Web of Science ®Google Scholar
• Bodger K, Wyatt J, Heatley R. Gastric mucosal secretion of interleukin-10: relations to histopathology, Helicobacter pylori status, and tumour necrosis factor-alpha secretion. Gut. 1997;40(6):739–744.
   PubMed Web of Science ®Google Scholar
• Kindlund B, Sjöling Å, Yakkala C, et al. CD4+ regulatory T cells in gastric cancer mucosa are proliferating and express high levels of IL-10 but little TGF-β. Gastric Cancer. 2017;20(1):116–125.
   PubMed Web of Science ®Google Scholar
• Torisu M, Murakami H, Akbar F, et al. Protective role of interleukin-10-producing regulatory dendritic cells against murine autoimmune gastritis. J Gastroenterol. 2008;43(2):100–107.
   PubMed Web of Science ®Google Scholar
• Asseman C, Mauze S, Leach MW, et al. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med. 1999;190(7):995–1004.
   PubMed Web of Science ®Google Scholar
• Bridgewood C, Newton D, Bragazzi N, et al. Unexpected connections of the IL-23/IL-17 and IL-4/IL-13 cytokine axes in inflammatory arthritis and enthesitis. Semin Immunol. 2021;58:101520.
   PubMed Web of Science ®Google Scholar
• Petersen CP, Meyer AR, De Salvo C, et al. A signalling cascade of IL-33 to IL-13 regulates metaplasia in the mouse stomach. Gut. 2018;67(5):805–817.
   PubMed Web of Science ®Google Scholar
• Duffen J, Zhang M, Masek-Hammerman K, et al. Modulation of the IL-33/IL-13 axis in obesity by IL-13Ralpha2. J Immunol. 2018;200(4):1347–1359.
   PubMed Web of Science ®Google Scholar
• Amo-Aparicio J, Garcia-Garcia J, Francos-Quijorna I, et al. Interleukin-4 and interleukin-13 induce different metabolic profiles in microglia and macrophages that relate with divergent outcomes after spinal cord injury. Theranostics. 2021;11(20):9805–9820.
   PubMed Web of Science ®Google Scholar
• Conde E, Bertrand R, Balbino B, et al. Dual vaccination against IL-4 and IL-13 protects against chronic allergic asthma in mice. Nat Commun. 2021;12(1):2574.
   PubMed Web of Science ®Google Scholar
• May RD, Fung M. Strategies targeting the IL-4/IL-13 axes in disease. Cytokine. 2015;75(1):89–116.
   PubMed Web of Science ®Google Scholar
• Tu E, Ang DK, Bellingham SA, et al. Both IFN‐γ and IL‐17 are required for the development of severe autoimmune gastritis. Eur J Immunol. 2012;42(10):2574–2583.
   PubMed Web of Science ®Google Scholar
• Jones CM, Callaghan JM, Gleeson PA, et al. The parietal cell autoantibodies recognized in neonatal thymectomy-induced murine gastritis are the α and β subunits of the gastric proton pump. Gastroenterology. 1991;101(2):287–294.
   PubMed Web of Science ®Google Scholar
• Zandi F, Bagheri N, Rahimian G, et al. Evaluation of H. pylori infection and IL23R gene polymorphism in dyspeptic subjects. Life Sci J. 2014;11(SPEC. I):40–46.
   Google Scholar
• Toh B-H, Sentry JW, Alderuccio F. The causative H+/K+ ATPase antigen in the pathogenesis of autoimmune gastritis. Immunol Today. 2000;21(7):348–354.
   PubMedGoogle Scholar
• Hu Z, Chai J. Structural mechanisms in NLR inflammasome assembly and signaling. Curr Top Microbiol Immunol. 2016;397:23–42.
   Google Scholar
• Park H, Li Z, Yang XO, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005;6(11):1133–1141.
   PubMed Web of Science ®Google Scholar
• McHugh RS, Shevach EM, Margulies DH, et al. At cell receptor transgenic model of severe, spontaneous organ‐specific autoimmunity. Eur J Immunol. 2001;31(7):2094–2103.
   PubMed Web of Science ®Google Scholar
• Azadegan-Dehkordi F, Abbasi A, Abadi ATB, et al. From genes polymorphisms to mucosal expression of cytokines: evaluating IL-23/IL-17 axis in adult patients with gastritis. Afr Health Sci. 2020;20(3):1452–1462.
   PubMed Web of Science ®Google Scholar
• Kolls JK, Lindén A. Interleukin-17 family members and inflammation. Immunity. 2004;21(4):467–476.
   PubMed Web of Science ®Google Scholar
• Moseley T, Haudenschild DR, Rose L, et al. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev. 2003;14(2):155–174.
   PubMed Web of Science ®Google Scholar
• Long D, Chen Y, Wu H, et al. Clinical significance and immunobiology of IL-21 in autoimmunity. J Autoimmun. 2019;99:1–14.
   PubMed Web of Science ®Google Scholar
• Davis MR, Zhu Z, Hansen DM, et al. The role of IL-21 in immunity and cancer. Cancer Lett. 2015;358(2):107–114.
   PubMed Web of Science ®Google Scholar
• Huang Y, Zhang J, Wang G, et al. Oxymatrine exhibits anti-tumor activity in gastric cancer through inhibition of IL-21R-mediated JAK2/STAT3 pathway. Int J Immunopathol Pharmacol. 2018;32:2058738418781634.
   Web of Science ®Google Scholar
• Ren HM, Lukacher AE, Rahman ZS, et al. New developments implicating IL-21 in autoimmune disease. J Autoimmun. 2021;122:102689.
   PubMed Web of Science ®Google Scholar
• Spolski R, Leonard WJ. Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu Rev Immunol. 2008;26:57–79.
   PubMed Web of Science ®Google Scholar
• Nishiura H, Iwamoto S, Kido M, et al. Interleukin‐21 and tumor necrosis factor‐α are critical for the development of autoimmune gastritis in mice. J Gastroenterol Hepatol. 2013;28(6):982–991.
   PubMed Web of Science ®Google Scholar
• Meka RR, Venkatesha SH, Dudics S, et al. IL-27-induced modulation of autoimmunity and its therapeutic potential. Autoimmun Rev. 2015;14(12):1131–1141.
   PubMed Web of Science ®Google Scholar
• Wojno EDT, Hunter CA, Stumhofer JS. The immunobiology of the interleukin-12 family: room for discovery. Immunity. 2019;50(4):851–870.
   PubMed Web of Science ®Google Scholar
• Hunter CA, Kastelein R. Interleukin-27: balancing protective and pathological immunity. Immunity. 2012;37(6):960–969.
   PubMed Web of Science ®Google Scholar
• Rocha GA, de Melo FF, Cabral MM, et al. Interleukin‐27 is abrogated in gastric cancer, but highly expressed in other Helicobacter pylori‐associated gastroduodenal diseases. Helicobacter. 2020;25(1):e12667.
   PubMed Web of Science ®Google Scholar
• Lucas S, Ghilardi N, Li J, et al. IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and-independent mechanisms. Proc Natl Acad Sci. 2003;100(25):15047–15052.
   PubMed Web of Science ®Google Scholar
• Bockerstett KA, Petersen CP, Noto CN, et al. Interleukin 27 protects from gastric atrophy and metaplasia during chronic autoimmune gastritis. Cell Mol Gastroenterol Hepatol. 2020;10(3):561–579.
   PubMed Web of Science ®Google Scholar
• Billiau A, Heremans H, Vermeire K, et al. Immunomodulatory Properties of interferon‐γ: an update a. Ann N Y Acad Sci. 1998;856(1):22–32.
   PubMedGoogle Scholar
• Kelchtermans H, Billiau A, Matthys P. How interferon-γ keeps autoimmune diseases in check. Trends Immunol. 2008;29(10):479–486.
   PubMed Web of Science ®Google Scholar
• Silva D, Driel V, Gruta L. CD4+ T cells, but not CD8+ T cells, are required for the development of experimental autoimmune gastritis. Immunology. 1998;93(3):405–408.
   PubMed Web of Science ®Google Scholar
• Nakanishi Y, Lu B, Gerard C, et al. CD8+ T lymphocyte mobilization to virus-infected tissue requires CD4+ T-cell help. Nature. 2009;462(7272):510–513.
   PubMed Web of Science ®Google Scholar
• Osaki LH, Bockerstett KA, Wong CF, et al. Interferon-gamma directly induces gastric epithelial cell death and is required for progression to metaplasia. J Pathol. 2019;247(4):513–523.
   PubMed Web of Science ®Google Scholar
• Fabbri C, Jaboli MF, Giovanelli S, et al. Gastric autoimmune disorders in patients with chronic hepatitis C before, during and after interferon-alpha therapy. World J Gastroenterol. 2003;9(7):1487–1490.
   PubMed Web of Science ®Google Scholar
• Iwamoto S, Kido M, Aoki N, et al. IFN-γ is reciprocally involved in the concurrent development of organ-specific autoimmunity in the liver and stomach. Autoimmunity. 2012;45(2):186–198.
   PubMed Web of Science ®Google Scholar
• Shevach EM, Davidson TS, Huter EN, et al. Role of TGF-β in the induction of Foxp3 expression and T regulatory cell function. Journal of Clinical Immunology. 2008;28(6):640–646.
   PubMed Web of Science ®Google Scholar
• Marie JC, Letterio JJ, Gavin M, et al. TGF-β1 maintains suppressor function and Foxp3 expression in CD4+ CD25+ regulatory T cells. J Exp Med. 2005;201(7):1061–1067.
   PubMed Web of Science ®Google Scholar
• DiPaolo RJ, Brinster C, Davidson TS, et al. Autoantigen-specific TGFβ-induced Foxp3+ regulatory T cells prevent autoimmunity by inhibiting dendritic cells from activating autoreactive T cells. J Immunol. 2007;179(7):4685–4693.
   PubMed Web of Science ®Google Scholar
• Huter EN, Stummvoll GH, DiPaolo RJ, et al. Cutting edge: antigen-specific TGFβ-induced regulatory T cells suppress Th17-mediated autoimmune disease. J Immunol. 2008;181(12):8209–8213.
   PubMed Web of Science ®Google Scholar
• Tong Y, Wang R, Liu X, et al. Zuojin Pill ameliorates chronic atrophic gastritis induced by MNNG through TGF-β1/PI3K/akt axis. J Ethnopharmacol. 2021;271:113893.
   PubMed Web of Science ®Google Scholar
• Roan F, Bell BD, Stoklasek TA, et al. The multiple facets of thymic stromal lymphopoietin (TSLP) during allergic inflammation and beyond. J Leukoc Biol. 2012;91(6):877–886.
   PubMed Web of Science ®Google Scholar
• Leonard WJ. TSLP: finally in the limelight. Nat Immunol. 2002;3(7):605–607.
   PubMed Web of Science ®Google Scholar
• Ohno T, Nakamura T, Nakae S, et al. TSLP is a negative regulator of RANKL-induced osteoclastogenesis. Biochem Biophys Res Commun. 2020;530(3):508–512.
   PubMed Web of Science ®Google Scholar
• Marković I, Savvides SN. Modulation of signaling mediated by TSLP and IL-7 in inflammation, autoimmune diseases, and cancer. Front Immunol. 2020;11:1557.
   PubMed Web of Science ®Google Scholar
• Adhikary PP, Tan Z, Page BD, et al. TSLP as druggable target-a silver-lining for atopic diseases? Pharmacol Ther. 2021;217:107648.
   PubMed Web of Science ®Google Scholar
• Ziegler SF, Roan F, Bell BD, et al. The biology of thymic stromal lymphopoietin (TSLP). Adv Pharmacol. 2013;66:129–155.
   PubMedGoogle Scholar
• Shubin NJ, Clauson M, Niino K, et al. Thymic stromal lymphopoietin protects in a model of airway damage and inflammation via regulation of caspase-1 activity and apoptosis inhibition. Mucosal Immunol. 2020;13(4):584–594.
   PubMed Web of Science ®Google Scholar
• Barooei R, Mahmoudian RA, Abbaszadegan MR, et al. Evaluation of thymic stromal lymphopoietin (TSLP) and its correlation with lymphatic metastasis in human gastric cancer. Med Oncol. 2015;32(8):1–8.
   Web of Science ®Google Scholar
• Nishiura H, Kido M, Aoki N, et al. Increased susceptibility to autoimmune gastritis in thymic stromal lymphopoietin receptor-deficient mice. J Immunol. 2012;188(1):190–197.
   PubMed Web of Science ®Google Scholar
• Taylor BC, Zaph C, Troy AE, et al. TSLP regulates intestinal immunity and inflammation in mouse models of helminth infection and colitis. J Exp Med. 2009;206(3):655–667.
   PubMed Web of Science ®Google Scholar
• Tu E, Ang DK, Hogan TV, et al. A convenient model of severe, high incidence autoimmune gastritis caused by polyclonal effector T cells and without perturbation of regulatory T cells. PLoS One. 2011;6(11):e27153.
   PubMed Web of Science ®Google Scholar
• Malek TR. The main function of IL‐2 is to promote the development of T regulatory cells. J Leukoc Biol. 2003;74(6):961–965.
   PubMed Web of Science ®Google Scholar
• Taguchi O, Takahashi T. Administration of anti‐interleukin‐2 receptor α antibody in vivo induces localized autoimmune disease. Eur J Immunol. 1996;26(7):1608–1612.
   PubMed Web of Science ®Google Scholar
• Setoguchi R, Hori S, Takahashi T, et al. Homeostatic maintenance of natural Foxp3+ CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med. 2005;201(5):723–735.
   PubMed Web of Science ®Google Scholar
• Jiménez‐Garcia L, Herránz S, Luque A, et al. Critical role of p38 MAPK in IL‐4‐induced alternative activation of peritoneal macrophages. Eur J Immunol. 2015;45(1):273–286.
   PubMed Web of Science ®Google Scholar
• Yang T, Wang R, Liu H, et al. Berberine regulates macrophage polarization through IL-4-STAT6 signaling pathway in Helicobacter pylori-induced chronic atrophic gastritis. Life Sci. 2021;266:118903.
   PubMed Web of Science ®Google Scholar
• Nowak EC, Weaver CT, Turner H, et al. IL-9 as a mediator of Th17-driven inflammatory disease. J Exp Med. 2009;206(8):1653–1660.
   PubMed Web of Science ®Google Scholar
• Kar S, Gupta R, Malhotra R, et al. Interleukin-9 facilitates osteoclastogenesis in rheumatoid arthritis. Int J Mol Sci. 2021;22(19):10397.
   PubMed Web of Science ®Google Scholar
• Stephens GL, Swerdlow B, Benjamin E, et al. IL‐9 is a Th17‐derived cytokine that limits pathogenic activity in organ‐specific autoimmune disease. Eur J Immunol. 2011;41(4):952–962.
   PubMed Web of Science ®Google Scholar
• Kong H, You N, Chen H, et al. Helicobacter pylori-induced adrenomedullin modulates IFN-γ-producing T-cell responses and contributes to gastritis. Cell Death Dis. 2020;11(3):1–15.
   PubMed Web of Science ®Google Scholar
• Al-Sammak F, Kalinski T, Weinert S, et al. Gastric epithelial expression of IL-12 cytokine family in Helicobacter pylori infection in human: is it head or tail of the coin? PLoS One. 2013;8(9):e75192.
   PubMed Web of Science ®Google Scholar
• Okazaki K, Ohana M, Oshima C, et al. Interaction of Helicobacter pylori-induced follicular gastritis and autoimmune gastritis in BALB/c mice with post-thymectomy autoimmune gastritis. J Gastroenterol. 2003;38(12):1131–1137.
   PubMed Web of Science ®Google Scholar
• Amedei A, Bergman MP, Appelmelk BJ, et al. Molecular mimicry between Helicobacter pylori antigens and H+, K+–adenosine triphosphatase in human gastric autoimmunity. J Exp Med. 2003;198(8):1147–1156.
   PubMed Web of Science ®Google Scholar
• Ohana M, Okazaki K, Oshima C, et al. Inhibitory effects of Helicobacter pylori infection on murine autoimmune gastritis. Gut. 2003;52(8):1102–1110.
   PubMed Web of Science ®Google Scholar
• Youssefi M, Tafaghodi M, Farsiani H, et al. Helicobacter pylori infection and autoimmune diseases; is there an association with systemic lupus erythematosus, rheumatoid arthritis, autoimmune atrophy gastritis and autoimmune pancreatitis? A systematic review and meta-analysis study. J Microbiol Immunol Infect. 2021;54(3):359–369.
   PubMedGoogle Scholar
• Karczewski J, Poniedziałek B, Adamski Z, et al. The effects of the microbiota on the host immune system. Autoimmunity. 2014;47(8):494–504.
   PubMed Web of Science ®Google Scholar
• Parsons BN, Ijaz UZ, D’Amore R, et al. Comparison of the human gastric microbiota in hypochlorhydric states arising as a result of Helicobacter pylori-induced atrophic gastritis, autoimmune atrophic gastritis and proton pump inhibitor use. PLoS Pathog. 2017;13(11):e1006653.
   PubMed Web of Science ®Google Scholar
• Rajilic‐Stojanovic M, Figueiredo C, Smet A, et al. Systematic review: gastric microbiota in health and disease. Aliment Pharmacol Ther. 2020;51(6):582–602.
   PubMed Web of Science ®Google Scholar
• Conti L, Annibale B, Lahner E. Autoimmune gastritis and gastric microbiota. Microorganisms. 2020;8(11):1827.
   PubMed Web of Science ®Google Scholar
• Engstrand L, Graham DY. Microbiome and gastric cancer. Dig Dis Sci. 2020;65(3):865–873.
   PubMed Web of Science ®Google Scholar